Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein

Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein

US Patent 7541036 · Granted Jun 2, 2009

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of non-steroidal anti-inflammatory drugs by inhalation in the treatment of a2015
Monoclonal antibodies directed against the human immunodeficiency virus type 1 (2015
Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivatives having a1989
Theophyllinylmethyldioxolane derivatives, methods for their preparation and phar1983
Pharmaceutical compositions having anti-ulcer activity1981
Pharmaceutical composition with anti-bronchospasmodic and anti-tussive activity1980